| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Modelling, interpretation and forecasting of cancer mortality: a global perspective (2° anno)
|
|
Closed | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Cytoskeleton actin-binding proteins as determinants and new biomarkers of pituitary tumor invasiveness and drug response (4° anno)
|
|
Closed | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Advancing aetiology and prevention of gastric cancer: 5-year development of the Stomach cancer Pooling (StoP) Project (3° anno)
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
Characterisation and Long-Term Implications of Covid-19 related Atypical Thyroiditis
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
EMSG 60: Incidence trends of selected endocrine-related diseases and conditions in Europe and North America, and the contribution of changes in human reproduction
|
|
Closed | 2020 |
| FON_NAZ - Bandi Altre Fondazioni |
Inquinamento dell’aria e Sclerosi Multipla: ruolo dell’esposizione al particolato (PM) e del traffico di vescicole extracellulari associato nella neuroinfiammazione e demielinizzazione
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Development of novel research strategies fo the biological and clinical characterization of fatigue, a marker of aging, paradigm of complexity and potential target of interventions
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Early life stress, telomere attrition, and child prefrontal cortex functioning - 5° ANNO
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Modelling, interpretation and forecasting of cancer mortality: a global perspective (1° anno)
|
|
Closed | 2020 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Cytoskeleton actin-binding proteins as determinants and new biomarkers of pituitary tumor invasiveness and drug response (3° anno)
|
|
Closed | 2020 |
